We first used the tumor samples (6 MSS BRAF V600E, 26 MSS WT) and again used linear models and explained the average binding site methylation for each TF separately by the sample’s average methylation level across all TF sites, the number of methylation measurements overlapping with the TF binding sites, and BRAF mutation status. The gene discussed is BRAF; the disease is neoplasm.